Joel A Cassel (Joel Cassel)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Diffuse Large B Cell Lymphoma

Top Venues

Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Cancer discovery

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Felicite Majoumo-Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho, Cyril T Namba-Nzanguim, Conrad V Simoben, Donatus Bekindaka Eni, Mustafa A Isa, Adi Narayana Reddy Poli, Joel A Cassel, Joseph M Salvino, Luis J Montaner, Ian Tietjen, Fidele Ntie-Kang
5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2. Chemicke zvesti 78 (6) (2024)
Mariana J Shayo, Baraka Samwel, Daniel M Shadrack, Joel A Cassel, Joseph M Salvino, Luis J Montaner, Geradius Deogratias, Ian Tietjen, Lucy Kiruri, Samson Hilonga, Ester Innocent
Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins. RSC advances 14 (29) (2024)
Mariana J Shayo, Baraka Samwel, Daniel M Shadrack, Joel A Cassel, Joseph M Salvino, Luis J Montaner, Geradius Deogratias, Ian Tietjen, Lucy Kiruri, Samson Hilonga, Ester Innocent
Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins. RSC advances 14 (29) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Donatus Bekindaka Eni, Joel A Cassel, Cyril T Namba-Nzanguim, Conrad V Simoben, Ian Tietjen, Ravikumar Akunuri, Joseph M Salvino, Fidele Ntie-Kang
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction. Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents 33 (4) (2024)
Devivasha Bordoloi, Abhijeet J Kulkarni, Opeyemi S Adeniji, Maria Betina Pampena, Pratik S Bhojnagarwala, Shushu Zhao, Candice Ionescu, Alfredo Perales-Puchalt, Elizabeth M Parzych, Xizhou Zhu, Ali R Ali, Joel A Cassel, Rugang Zhang, Michael R Betts, Mohamed Abdel-Mohsen, David B Weiner
Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers. Science advances 9 (44) (2023)
Clare M Adams, Ramkrishna Mitra, You-Cai Xiao, Peter Michener, Juan Palazzo, Allen Chao, Jitendra Gour, Joel A Cassel, Joseph M Salvino, Christine M Eischen
Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer. Cancer discovery (2023)
Clare M Adams, Ramkrishna Mitra, You-Cai Xiao, Peter Michener, Juan Palazzo, Allen Chao, Jitendra Gour, Joel A Cassel, Joseph M Salvino, Christine M Eischen
Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer. Cancer discovery (2023)
Alexandra Indeglia, Jessica C Leung, Sven A Miller, Julia I-Ju Leu, James F Dougherty, Nicole L Clarke, Nicole A Kirven, Chunlei Shao, Lei Ke, Scott Lovell, Thibaut Barnoud, David Y Lu, Cindy Lin, Toshitha Kannan, Kevin P Battaile, Tyler Hong Loong Yang, Isabela Batista Oliva, Daniel T Claiborne, Peter Vogel, Lijun Liu, Jingjing Liu, Yulia Nefedova, Joel A Cassel, Noam Auslander, Andrew V Kossenkov, John Karanicolas, Maureen E Murphy
An African-specific variant of TP53 reveals PADI4 as a regulator of p53-mediated tumor suppression. Cancer discovery (2023)
Luke Invernizzi, Phanankosi Moyo, Joel A Cassel, Freddie J Isaacs, Joseph M Salvino, Luis J Montaner, Ian Tietjen, Vinesh J Maharaj
Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 binding. Analytical and bioanalytical chemistry 414 (13) (2022)
Troy E Messick, Garry R Smith, Samantha S Soldan, Mark E McDonnell, Julianna S Deakyne, Kimberly A Malecka, Lois Tolvinski, A Pieter J van den Heuvel, Bai-Wei Gu, Joel A Cassel, Donna H Tran, Benjamin R Wassermann, Yan Zhang, Venkata Velvadapu, Edward R Zartler, Pierre Busson, Allen B Reitz, Paul M Lieberman
Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Science translational medicine 11 (482) (2020)